Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

Maya H Buch; Josef S Smolen; Neil Betteridge; Ferdinand C Breedveld; Gerd Burmester; Thomas Dörner; Gianfranco Ferraccioli; Jacques-Eric Gottenberg; John Isaacs; Tore K Kvien; Xavier Mariette; Emilio Martin-Mola; Karel Pavelka; Paul P Tak; Desiree van der Heijde; Ronald F van Vollenhoven; Paul Emery; Rituximab Consensus Expert Committee; Mikkel Østergaard

doi:http://dx.doi.org/10.1136/ard.2010.144998

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

Maya H Buch, Josef S Smolen, Neil Betteridge, Ferdinand C Breedveld, Gerd Burmester, Thomas Dörner, Gianfranco Ferraccioli, Jacques-Eric Gottenberg, John Isaacs, Tore K Kvien, Xavier Mariette, Emilio Martin-Mola, Karel Pavelka, Paul P Tak, Desiree van der Heijde, Ronald F van Vollenhoven, Paul Emery, Rituximab Consensus Expert Committee, Mikkel Østergaard

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

367 Citationer (Scopus)

Abstract

Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has been evaluated in clinical trials involving various populations with RA. Information has also been gathered from registries. This report therefore updates the 2007 consensus document on the use of rituximab in the treatment of RA.

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	70
Udgave nummer	6
Sider (fra-til)	909-20
Antal sider	12
ISSN	0003-4967
DOI	https://doi.org/10.1136/ard.2010.144998
Status	Udgivet - 2011

Bibliografisk note

Mikkel Østergaard er tilføjet denne publikation som medlem af Rituximab Consensus Expert Committee

Adgang til dokumentet

http://dx.doi.org/10.1136/ard.2010.144998

Citationsformater

Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J-E., Isaacs, J., Kvien, T. K., Mariette, X., Martin-Mola, E., Pavelka, K., Tak, P. P., van der Heijde, D., van Vollenhoven, R. F., Emery, P., Rituximab Consensus Expert Committee, & Østergaard, M. (2011). Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 70(6), 909-20. https://doi.org/10.1136/ard.2010.144998

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. / Buch, Maya H; Smolen, Josef S; Betteridge, Neil; Breedveld, Ferdinand C; Burmester, Gerd; Dörner, Thomas; Ferraccioli, Gianfranco; Gottenberg, Jacques-Eric; Isaacs, John; Kvien, Tore K; Mariette, Xavier; Martin-Mola, Emilio; Pavelka, Karel; Tak, Paul P; van der Heijde, Desiree; van Vollenhoven, Ronald F; Emery, Paul; Rituximab Consensus Expert Committee ; Østergaard, Mikkel.

I: Annals of the Rheumatic Diseases, Bind 70, Nr. 6, 2011, s. 909-20.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Buch, MH, Smolen, JS, Betteridge, N, Breedveld, FC, Burmester, G, Dörner, T, Ferraccioli, G, Gottenberg, J-E, Isaacs, J, Kvien, TK, Mariette, X, Martin-Mola, E, Pavelka, K, Tak, PP, van der Heijde, D, van Vollenhoven, RF, Emery, P, Rituximab Consensus Expert Committee & Østergaard, M 2011, 'Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis', Annals of the Rheumatic Diseases, bind 70, nr. 6, s. 909-20. https://doi.org/10.1136/ard.2010.144998

Buch, Maya H ; Smolen, Josef S ; Betteridge, Neil ; Breedveld, Ferdinand C ; Burmester, Gerd ; Dörner, Thomas ; Ferraccioli, Gianfranco ; Gottenberg, Jacques-Eric ; Isaacs, John ; Kvien, Tore K ; Mariette, Xavier ; Martin-Mola, Emilio ; Pavelka, Karel ; Tak, Paul P ; van der Heijde, Desiree ; van Vollenhoven, Ronald F ; Emery, Paul ; Rituximab Consensus Expert Committee ; Østergaard, Mikkel. / Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. I: Annals of the Rheumatic Diseases. 2011 ; Bind 70, Nr. 6. s. 909-20.

@article{66a6ab7e175347d5bfdaaab65bb3fc02,

title = "Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis",

abstract = "Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has been evaluated in clinical trials involving various populations with RA. Information has also been gathered from registries. This report therefore updates the 2007 consensus document on the use of rituximab in the treatment of RA.",

author = "Buch, {Maya H} and Smolen, {Josef S} and Neil Betteridge and Breedveld, {Ferdinand C} and Gerd Burmester and Thomas D{\"o}rner and Gianfranco Ferraccioli and Jacques-Eric Gottenberg and John Isaacs and Kvien, {Tore K} and Xavier Mariette and Emilio Martin-Mola and Karel Pavelka and Tak, {Paul P} and {van der Heijde}, Desiree and {van Vollenhoven}, {Ronald F} and Paul Emery and Mikkel {\O}stergaard and Mikkel {\O}stergaard",

note = "Mikkel {\O}stergaard er tilf{\o}jet denne publikation som medlem af Rituximab Consensus Expert Committee",

year = "2011",

doi = "http://dx.doi.org/10.1136/ard.2010.144998",

language = "English",

volume = "70",

pages = "909--20",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "6",

}

TY - JOUR

T1 - Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

AU - Buch, Maya H

AU - Smolen, Josef S

AU - Betteridge, Neil

AU - Breedveld, Ferdinand C

AU - Burmester, Gerd

AU - Dörner, Thomas

AU - Ferraccioli, Gianfranco

AU - Gottenberg, Jacques-Eric

AU - Isaacs, John

AU - Kvien, Tore K

AU - Mariette, Xavier

AU - Martin-Mola, Emilio

AU - Pavelka, Karel

AU - Tak, Paul P

AU - van der Heijde, Desiree

AU - van Vollenhoven, Ronald F

AU - Emery, Paul

AU - Rituximab Consensus Expert Committee

AU - Østergaard, Mikkel

N1 - Mikkel Østergaard er tilføjet denne publikation som medlem af Rituximab Consensus Expert Committee

PY - 2011

Y1 - 2011

N2 - Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has been evaluated in clinical trials involving various populations with RA. Information has also been gathered from registries. This report therefore updates the 2007 consensus document on the use of rituximab in the treatment of RA.

AB - Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has been evaluated in clinical trials involving various populations with RA. Information has also been gathered from registries. This report therefore updates the 2007 consensus document on the use of rituximab in the treatment of RA.

U2 - http://dx.doi.org/10.1136/ard.2010.144998

DO - http://dx.doi.org/10.1136/ard.2010.144998

M3 - Journal article

VL - 70

SP - 909

EP - 920

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -